Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01871896 · ClinicalTrials.gov registry record · NA
Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01871896 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants.
The verdict
NCT01871896, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Morbid obesity and its associated metabolic diseases are on the rise in the United States. Currently, the best treatment for obesity is bariatric surgery where both roux-en-Y gastric bypass and sleeve gastrectomy offer substantial weight loss. Unfortunately, 20% of patients who undergo bariatric surgery fail to lose enough weight defined as less than 50% of excess body weight loss or regain of weight. For those patients who fail to lose weight after bariatric surgery and have failed maximal medical therapy and diet supervision, the treatment is re-operation and revision. Re-operation of the abdomen carries significant postoperative morbidity and mortality. The investigators propose to use the Apollo OverStitch endoscopic suturing device that has already been approved by the FDA as an option for bariatric surgery revision without having to re-operate on the patient. The investigators believe that the endoscopic technique may be able to provide weight loss without having to re-operate on the patient.
Interventions
- DEVICE Endoscopic Suturing to Create Early Satiety
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-01 |
| Est. Completion | 2022-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01871896
The ClinicalTrials.gov registry entry for NCT01871896 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic Suturing to Create Early Satiety is the first listed.
NCT01871896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01871896 about?
NCT01871896 is a clinical study titled "Endoscopic Surgery for Bariatric Revision After Weight Loss Failure". Morbid obesity and its associated metabolic diseases are on the rise in the United States. Currently, the best treatment for obesity is bariatric surgery where both roux-en-Y gastric bypass and sleeve gastrectomy offer substantial weight loss. Unfortunately, 20% of patients who undergo bariatric sur...
What is the current status of trial NCT01871896?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-01. Estimated completion is 2022-06.
What interventions are being tested in trial NCT01871896?
The interventions under investigation include: Endoscopic Suturing to Create Early Satiety (DEVICE).
Who is sponsoring clinical trial NCT01871896?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.